Abstract | OBJECTIVE: The role of platelet derived serotonin (5-HT) in collagen induced human platelet aggregation was examined both in hirudinised plasma and whole blood. Hirudin was used to maintain normocalcaemia, thereby avoiding erroneous findings often obtained with citrated blood. METHODS: Platelet aggregation, aggregate growth, and primary platelet aggregation were quantified by optical aggregometry and platelet counting respectively. RESULTS: In plasma, platelet aggregation induced by 5-HT (3 microM) in the presence of adrenaline (1 microM) was inhibited by more than 85% by ICI 170809 (3 microM, IC50 0.1 microM), a specific platelet 5-HT2 antagonist. With collagen (0.5 micrograms.ml-1), ICI 170809 retarded the rate of aggregation by 30%, whereas aspirin abolished the response. In contrast, ICI 170809 inhibited collagen induced primary aggregation by less than 10% in both plasma and whole blood. CONCLUSIONS: (1) 5-HT contributes to collagen induced aggregate growth and 5-HT2 receptor antagonism with ICI 170809 retards the rate of growth. (2) This could explain the efficacy of 5-HT2 antagonists in limiting coronary thrombosis despite the limited role of 5-HT in primary aggregation.
|
Authors | V C Menys |
Journal | Cardiovascular research
(Cardiovasc Res)
Vol. 27
Issue 11
Pg. 1916-9
(Nov 1993)
ISSN: 0008-6363 [Print] England |
PMID | 8287397
(Publication Type: Journal Article)
|
Chemical References |
- Hirudins
- Quinolines
- Recombinant Proteins
- Serotonin Antagonists
- Serotonin
- ICI 170809
- Collagen
- Apyrase
- Aspirin
- desirudin
- Epinephrine
|
Topics |
- Apyrase
(pharmacology)
- Aspirin
(pharmacology)
- Blood Platelets
(drug effects)
- Collagen
(pharmacology)
- Epinephrine
(pharmacology)
- Hirudins
(analogs & derivatives, pharmacology)
- Humans
- In Vitro Techniques
- Platelet Aggregation
(drug effects)
- Platelet Count
- Quinolines
(pharmacology)
- Recombinant Proteins
(pharmacology)
- Serotonin
(pharmacology)
- Serotonin Antagonists
(pharmacology)
|